Literature DB >> 10353950

Practice parameter: long-term treatment of the child with simple febrile seizures. American Academy of Pediatrics. Committee on Quality Improvement, Subcommittee on Febrile Seizures.

.   

Abstract

The Committee on Quality Improvement, Subcommittee on Febrile Seizures, of the American Academy of Pediatrics, in collaboration with experts from the Section on Neurology, general pediatricians, consultants in the fields of child neurology and epilepsy, and research methodologists, developed this practice parameter. This guideline provides recommendations for the treatment of a child with simple febrile seizures. These recommendations are derived from a thorough search and analysis of the literature. The methods and results of the literature review can be found in the accompanying technical report. This guideline is designed to assist pediatricians by providing an analytic framework for the treatment of children with simple febrile seizures. It is not intended to replace clinical judgment or establish a protocol for all patients with this condition. It rarely will be the only appropriate approach to the problem. The technical report entitled "Treatment of the Child With Simple Febrile Seizures" provides in-depth information on the studies used to form guideline recommendations. A complete bibliography is included as well as evidence tables that summarize data extracted from scientific studies. This report also provides pertinent evidence on the individual therapeutic agents studied including study results and dosing information. Readers of this clinical practice guideline are urged to review the technical report to enhance the evidence-based decision-making process. The report is available on the Pediatrics electronic pages website at the following URL: http://www.pediatrics.org/cgi/content/full/103/6/e86.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353950     DOI: 10.1542/peds.103.6.1307

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  The National Children's Study (NCS): establishment and protection of the inferential base.

Authors:  Jonas H Ellenberg
Journal:  Stat Med       Date:  2010-06-15       Impact factor: 2.373

Review 2.  Febrile seizures.

Authors:  Lynette G Sadleir; Ingrid E Scheffer
Journal:  BMJ       Date:  2007-02-10

3.  Thiol/disulfide homeostasis as a novel indicator of oxidative stress in children with simple febrile seizures.

Authors:  Bahri Elmas; Özcan Erel; Dilek Ersavaş; Yusuf Yürümez
Journal:  Neurol Sci       Date:  2017-08-14       Impact factor: 3.307

Review 4.  Neuropeptide Y: potential role in recurrent developmental seizures.

Authors:  Celine Dubé
Journal:  Peptides       Date:  2006-12-29       Impact factor: 3.750

5.  Endogenous neuropeptide Y prevents recurrence of experimental febrile seizures by increasing seizure threshold.

Authors:  Céline Dubé; Kristen L Brunson; Mariam Eghbal-Ahmadi; Rebeca Gonzalez-Vega; Tallie Z Baram
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 6.  Prevention and management of febrile seizures.

Authors:  R J Baumann
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

7.  Distribution of febrile seizure duration and associations with development.

Authors:  Dale C Hesdorffer; Emma K T Benn; Emilia Bagiella; Douglas Nordli; John Pellock; Veronica Hinton; Shlomo Shinnar
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

Review 8.  Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

9.  Febrile seizures.

Authors:  Rajiv R Varma
Journal:  Indian J Pediatr       Date:  2002-08       Impact factor: 1.967

10.  The Effects of Amiloride on Seizure Activity, Cognitive Deficits and Seizure-Induced Neurogenesis in a Novel Rat Model of Febrile Seizures.

Authors:  Tang-Peng Ou-Yang; Ge-Min Zhu; Yin-Xiu Ding; Feng Yang; Xiao-Long Sun; Wen Jiang
Journal:  Neurochem Res       Date:  2015-12-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.